Proteins are essential molecules that carry out nearly all functions in living organisms. They work by interacting with other molecules, such as small compounds, metabolites, or drugs. Understanding these interactions at the atomic level is crucial for biology and medicine. Today, most available techniques provide mainly static pictures of proteins, making it difficult to understand why some interactions are strong, others are weak, and why certain drugs bind only to specific sites. These limitations restrict progress in fields such as drug design, enzyme engineering and the study of diseases driven by malfunctioning proteins.
The CLAR project aims to overcome this gap by developing a new way to measure the thermodynamic forces that drive molecular interactions, and to do so with atomic resolution. The project uses advanced nuclear magnetic resonance (NMR) spectroscopy combined with computational modelling to create an “atomic calorimeter”, a tool capable of revealing how energy and entropy contribute to protein structure, stability and binding. By doing so, CLAR seeks to provide insights that cannot be obtained from structural data alone.
The overall objectives are:
• to build a framework that links NMR observables to thermodynamic quantities at the level of individual atoms;
• to map free-energy landscapes and identify regions of proteins that control folding, flexibility and binding;
• to apply this approach to proteins and protein–ligand complexes to reveal how dynamic features influence biological functions;
• to open the way for more rational and quantitative strategies in drug discovery.
The expected impact of the project is significant. A deeper understanding of atomic-level thermodynamics will help scientists interpret biomolecular behaviour more accurately and could support the development of new drugs, especially for targets that are difficult to study with existing methods.